The Magazine for Sleep Professionals
Sunday, September 27, 2026
ResMed announced that it has entered into a definitive agreement to acquire Noctrix Health, a medical technology company focused on treating restless legs syndrome (RLS). The acquisition marks a strategic expansion of ResMed’s portfolio into adjacent neurological sleep disorders, reinforcing its mission to improve patient outcomes and quality of life. […]
Noctrix Health, Inc., the developer of the Nidra® Tonic Motor Activation (TOMAC) therapy for Restless Legs Syndrome (RLS), announced a significant expansion of private financing to accelerate its U.S. commercial launch. The company also announced several key leadership appointments to strengthen its commercial and scientific teams. Financing Update Noctrix Health […]
A new clinical practice guideline developed by the American Academy of Sleep Medicine provides updated recommendations for the treatment of restless legs syndrome. The guideline reflects the latest scientific evidence and recommends significant changes in the standard treatment of RLS in adults. Available online as an accepted paper in the […]
Noctrix Health, Inc. announced a double feature in the renowned peer-reviewed journal, Sleep, showcasing the outcomes of two major clinical trials that assessed TOMAC therapy for the treatment of restless legs syndrome (RLS). The two papers feature the results from the RESTFUL study (NCT04874155), a multi-center, randomized, sham-controlled clinical trial, and a subsequent […]
New scientific findings offer hope and a natural solution to those who suffer from sensations of crawling, pulling, throbbing, aching and itching in the legs, often resulting in sleep disruption and the uncontrollable urge to move. Restless Legs Syndrome (RLS) impacts nearly 10 percent of the U.S. population and can lead to […]
Noctrix Health, Inc. announced that the first patient has been enrolled in a multi-center, randomized controlled clinical trial. The RESTFUL Study (ClinicalTrials.gov Identifier: NCT04874155) is a first of its kind two-phase, randomized, double-blind, sham-controlled clinical trial to evaluate the Company’s proprietary wearable NTX100 Neuromodulation System in patients with moderate-severe primary RLS […]
By Dr. Charles Kravitz ADHD (Attention Deficit Hyperactivity Disorder) is linked to a variety of sleep problems. For example, one recent study found that children with ADHD had higher rates of daytime sleepiness than children without ADHD. Another study found that 50% of children with ADHD had signs of sleep-disordered breathing, compared to only 22% […]
Possible relationship between gut microbial health and sleep disorder Small intestine bacterial overgrowth (SIBO) may be more prevalent among patients with restless legs syndrome (RLS), according to preliminary findings from a small, new study. Results show that SIBO was found in all seven participants who have RLS. In contrast, the prevalence […]
15 November 2018 New research published in The Journal of Physiology presents a breakthrough in the treatment of Restless Legs Syndrome (RLS) RLS is a common condition of the nervous system that causes an overwhelming, irresistible urge to move the legs. Patients complain of unpleasant symptoms such as tingling, burning and painful cramping sensations […]
